The U.S. House of Representatives has passed a package of key cryptocurrency bills championed by President Donald Trump. The most important among them — the GENIUS Act — received bipartisan support (308 votes in favor, 122 against) and, after previously being approved by the Senate in June, now heads to Trump's desk. The bill introduces a regulatory framework for stablecoins, requiring issuers to comply with anti-money laundering and sanctions regulations. The House also passed the CLARITY Act (defining general crypto market regulatory principles) and the Anti-CBDC Surveillance State Act, which aims to block the creation of a U.S. central bank digital currency (CBDC). The latter two bills are still awaiting Senate approval.
In parallel, Trump is preparing an executive order that would allow $9 trillion in American retirement savings (from 401(k) accounts) to be invested in alternative assets such as cryptocurrencies, gold, and private equity — potentially transforming the structure of the U.S. retirement system.
Source: XTB Research
As legislative progress accelerates, the crypto market is booming. Ethereum is up 51% since the beginning of July, and Bitcoin remains above the $120,000 mark. Altcoins are also gaining, supported by growing institutional interest and reports that giants like Walmart and Amazon are considering issuing their own stablecoins to reduce transaction costs. Market leaders are calling these developments a "breakthrough moment," offering hope for regulatory clarity, increased investor confidence, and a green light for widespread crypto adoption.
Institutions are allocating increasing capital into Ethereum. Stablecoin adoption could significantly boost demand for the second-largest cryptocurrency. A notable accumulation trend can be seen via BlackRock’s ETF. Source: XTB Research
Ethereum (D1)
Ethereum is seeing strong gains. However, unlike Bitcoin, Ethereum is still over 33% below its previous all-time high set in November 2021.
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.